journal
Journals Clinical and Experimental Neph...

Clinical and Experimental Nephrology

https://read.qxmd.com/read/38888720/a-comparison-of-the-clinical-efficacy-of-tonsillectomy-with-steroid-pulse-therapy-and-tonsillectomy-therapy-alone-for-patients-with-immunoglobulin-a-nephropathy-a-retrospective-observational-study
#41
JOURNAL ARTICLE
Ryosuke Sato, Risa Wakisaka, Hiroki Komatsuda, Hidekiyo Yamaki, Kenzo Ohara, Takumi Kumai, Kan Kishibe, Naoki Nakagawa, Tatsuya Hayashi, Miki Takahara
BACKGROUND: Tonsillectomy with steroid pulse therapy (TSP) and tonsillectomy monotherapy (T) have improved the prognosis of patients with immunoglobulin A nephropathy (IgAN). However, a consensus has not been reached on the best treatment for these patients. This study aimed to compare the efficacies of TSP and T. METHODS: Data of patients with IgAN who received TSP or T were retrospectively analyzed. The exclusion criterion was a serum creatinine level > 1...
June 18, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38879735/adverse-reactions-and-effects-on-renal-function-of-covid-19-vaccines-in-patients-with-iga-nephropathy
#42
JOURNAL ARTICLE
Katsushi Nagatsuji, Takashi Morikawa, Natsuki Ide, Ryuichi Kunishige, Shiho Takahata, Aoi Matsuki, Keita Kadosawa, Yuko Sakata, Daisuke Yamazaki, Mikiko Shibata, Masahiro Hamada, Chizuko Kitabayashi, Akira Nishiyama, Yoshio Konishi
BACKGROUND: Although vaccination has been reported to reduce the morbidity and severity of COVID-19 infection in patients with kidney disease, gross hematuria is frequently reported following vaccination in patients with IgA nephropathy. We investigated the frequency of gross hematuria following COVID-19 vaccination and its effect on renal function in IgA nephropathy patients. METHODS: Adverse reactions after two or more COVID-19 vaccine doses were investigated in 295 IgA nephropathy patients attending Osaka Cty general hospital from September 2021 to November 2022...
June 15, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38877226/evaluation-of-pathogenicity-of-wt1-intron-variants-by-in-vitro-splicing-analysis
#43
JOURNAL ARTICLE
Seiya Inoue, Atsushi Kondo, Yuta Inoki, Yuta Ichikawa, Yu Tanaka, Chika Ueda, Hideaki Kitakado, Ryota Suzuki, Eri Okada, Nana Sakakibara, Tomoko Horinouchi, Kandai Nozu
BACKGROUND: Wilms tumor 1 (WT1; NM_024426) causes Denys-Drash syndrome, Frasier syndrome, or isolated focal segmental glomerulosclerosis. Several WT1 intron variants are pathogenic; however, the pathogenicity of some variants remains undefined. Whether a candidate variant detected in a patient is pathogenic is very important for determining the therapeutic options for the patient. METHODS: In this study, we evaluated the pathogenicity of WT1 gene intron variants with undetermined pathogenicity by comparing their splicing patterns with those of the wild-type using an in vitro splicing assay using minigenes...
June 14, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38872014/oral-alkalinizing-supplementation-suppressed-intrarenal-reactive-oxidative-stress-in-mild-stage-chronic-kidney-disease-a-randomized-cohort-study
#44
JOURNAL ARTICLE
Michiaki Abe, Takuhiro Yamaguchi, Seizo Koshiba, Shin Takayama, Toshiki Nakai, Koichiro Nishioka, Satomi Yamasaki, Kazuhiko Kawaguchi, Masanori Umeyama, Atsuko Masaura, Kota Ishizawa, Ryutaro Arita, Takeshi Kanno, Tetsuya Akaishi, Mariko Miyazaki, Takaaki Abe, Tetsuhiro Tanaka, Tadashi Ishii
BACKGROUND: The beneficial effects of oral supplements with alkalinizing agents in patients with chronic kidney disease (CKD) have been limited to the severe stages. We investigated whether two types of supplements, sodium bicarbonate (SB) and potassium citrate/sodium citrate (PCSC), could maintain renal function in patients with mild-stage CKD. METHODS: This was a single-center, open-labeled, randomized cohort trial. Study participants with CKD stages G2, G3a, and G3b were enrolled between March 2013 and January 2019 and randomly assigned by stratification according to age, sex, estimated glomerular filtration rate (eGFR), and diabetes...
June 13, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38851645/prognosis-of-microscopic-polyangiitis-is-well-predictable-in-the-first-2-weeks-of-treatment
#45
JOURNAL ARTICLE
Akiko Owaki, Akihito Tanaka, Kazuhiro Furuhashi, Yu Watanabe, Eri Koshi-Ito, Takahiro Imaizumi, Shoichi Maruyama
BACKGROUND: Kidney and life outcomes remain unsatisfactory in patients with microscopic polyangiitis (MPA). Appropriate treatment intensity must be provided to the appropriate patients. To identify severe cases early, we investigated the factors related to kidney and life outcomes. METHODS: We included patients diagnosed with MPA based on myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) positivity and kidney histopathology results after kidney biopsies between January 1, 2021, and May 11, 2023, at 10 affiliated centers, including our hospital...
June 8, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38831157/relapse-during-and-after-regular-single-dose-rituximab-treatment-in-adult-patients-with-steroid-dependent-nephrotic-syndrome
#46
JOURNAL ARTICLE
Eiichiro Saito, Atsushi Oura, Tetsuya Kyo, Shun Ishigaki, Hitomi Kamei, Yuki Nakamura, Jun Soma, Izaya Nakaya
BACKGROUND: Rituximab is widely used in patients with steroid-dependent nephrotic syndrome. However, information on the effect of long-term rituximab treatment is limited. This study examined the efficacy of rituximab during and after treatment in adult patients with steroid-dependent nephrotic syndrome. METHODS: This retrospective cohort study included 30 patients with steroid-dependent nephrotic syndrome. Patients received regular single-dose rituximab (500 mg) intravenously every 6 months...
June 4, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38831156/analysis-of-the-impact-of-obesity-on-the-prognosis-of-iga-nephropathy-according-to-renal-function-and-sex
#47
JOURNAL ARTICLE
Yuki Ariyasu, Kazuo Torikoshi, Tatsuo Tsukamoto, Takashi Yasuda, Yoshinari Yasuda, Keiichi Matsuzaki, Keita Hirano, Tetsuya Kawamura, Takashi Yokoo, Shoichi Maruyama, Yusuke Suzuki, Eri Muso
BACKGROUND: Few studies have observed the direct effect of obesity on renal prognoses in immunoglobulin A nephropathy (IgAN) or separately evaluated its effects according to sex. We aimed to evaluate the direct and indirect effects of obesity on the renal outcomes of IgAN and observe these effects separately according to renal function and sex. METHODS: We extracted patients with body mass index (BMI) descriptions from a multicenter retrospective cohort analysis in Japan, and excluded those with < 30 days of follow-up, diabetes mellitus, and steroid treatment...
June 4, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38396314/the-impact-of-low-and-high-dialysate-calcium-concentrations-on-cardiovascular-disease-and-death-in-patients-undergoing-maintenance-hemodialysis-a-systematic-review-and-meta-analysis
#48
JOURNAL ARTICLE
Keita Kamei, Shunsuke Yamada, Koji Hashimoto, Tsuneo Konta, Takayuki Hamano, Masafumi Fukagawa
BACKGROUND: The optimal dialysate calcium (Ca) concentration for patients undergoing hemodialysis remains inconclusive, particularly concerning cardiovascular protection. METHODS: We conducted a systematic review of 19 randomized controlled trials (RCTs) and a meta-analysis of eight RCTs to determine the optimal dialysate Ca concentration for cardiovascular protection. We compared outcomes in patients receiving maintenance hemodialysis treated with either a low-Ca dialysate (LCD) (1...
June 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38814420/differences-in-characteristics-and-risk-factors-for-acute-kidney-injury-between-elderly-and-very-elderly-patients-a-retrospective-review
#49
JOURNAL ARTICLE
Yutaka Hatakeyama, Taro Horino, Shigehiro Yasui, Yoshio Terada, Yoshiyasu Okuhara
BACKGROUND: Few epidemiologic studies on acute kidney injury (AKI) have focused on the older adult population. This study aimed to clarify the characteristics and risk factors for AKI in this population. METHODS: This retrospective observational study was performed with the clinical data of all outpatients and inpatients aged ≥ 65 years at the time of enrolment at Kochi Medical School Hospital between 1 January 1981 and 31 December 2021. The primary cohort was divided into those aged 65-74 and ≥ 75 years...
May 30, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38789827/association-between-alcohol-consumption-and-chronic-kidney-disease-a-population-based-survey
#50
JOURNAL ARTICLE
I-Chun Chen, Wan-Chuan Tsai, Le-Yin Hsu, Mei-Ju Ko, Kuo-Liong Chien, Kuan-Yu Hung, Hon-Yen Wu
BACKGROUND: Alcohol consumption is associated with both beneficial and harmful effects, and the role of alcohol consumption in chronic kidney disease (CKD) remains inconclusive. This study aimed to investigate the relationship between alcohol consumption and CKD or estimated glomerular filtration rate (eGFR). METHODS: This study enrolled adults from the second Taiwanese Survey on Prevalences of Hypertension, Hyperglycemia, and Hyperlipidemia, conducted in 2007. Participants were categorized into frequent drinkers, occasional drinkers, and nondrinkers...
May 25, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38782822/one-anastomosis-gastric-bypass-ameliorates-diabetic-nephropathy-via-regulating-the-glp-1-mediated-sirt1-ampk-pgc1%C3%AE-pathway
#51
JOURNAL ARTICLE
Lang Han, Xiaojiao Chen, Dianwei Wan, Min Xie, Shurui Ouyang
BACKGROUND: Diabetic nephropathy (DN), a complication of diabetes, is the most leading cause of end-stage renal disease. Bariatric surgery functions on the remission of diabetes and diabetes-related complications. One anastomosis gastric bypass (OAGB), one of popular bariatric surgery, can improve diabetes and its complications by regulating the glucagon-like peptide-1 (GLP-1) level. Meanwhile, GLP-1 can alleviate renal damage in high-fat-diet-induced obese rats. However, the effect of OAGB on renal injury remains uncertain in DN...
May 23, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38767689/the-ratio-of-high-aspartate-aminotransferase-to-alanine-aminotransferase-an-independent-risk-factor-associated-with-poor-prognosis-in-iga-nephropathy
#52
JOURNAL ARTICLE
Hailang Wei, Bingqing Liao, Qi Zhou, Xuhua Zhou, Yue Zhong, Yanbin Hao, Fuhua Xie, Runxiu Wang
OBJECTIVE: To investigate the relationship between the aspartate aminotransferase to alanine aminotransferase ratio (AAR) and the prognosis of IgA nephropathy (IgAN). METHODS: Clinical, pathological and follow-up data of 271 patients with IgAN from January 1, 2013, to July 31, 2023, were collected. A 50% decrease in estimated glomerular filtration rate (eGFR) or end-stage renal disease (ESRD) was used as renal composite end point events. A receiver operating characteristic (ROC) curve was plotted to predict the composite end point events by AAR...
May 20, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38767688/the-comparison-of-four-hypoxia-inducible-factor-prolyl-hydroxylase-inhibitors-on-drug-potency-and-cost-for-treatment-in-patients-with-renal-anemia
#53
JOURNAL ARTICLE
Enyu Imai, Atsuhiro Imai
BACKGROUND: Five hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) have been approved for marketing in Japan. However, marked differences exist in terms of drug potency, dose requirement, and pharmacokinetics. METHODS: The primary evaluation in this study was the changes in hemoglobin levels, dose escalation, drug potency, and cost among HIF-PHIs, 3 months after the initiation of treatment. RESULTS: All patients treated with HIF-PHI between August 2020 and December 2023 were enrolled in this study...
May 20, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38767687/high-body-mass-index-and-triglyceride-levels-at-health-checkups-increase-the-risk-of-new-onset-chronic-kidney-disease-and-worsening-renal-function-the-tama-med-project-ckd
#54
JOURNAL ARTICLE
Tomohiro Kaneko, Eitaro Kodani, Hitomi Fujii, Hiroyuki Nakamura, Hajime Sasabe, Yutaka Tamura
BACKGROUND: Health checkups are important in patients with chronic kidney disease (CKD), which is not easily accompanied by subjective symptoms. CKD can be caused or aggravated by factors that have not yet been identified. METHODS: This retrospective cohort study included 7 483 patients who underwent specific annual health checkups at a medical institution in Tama City, did not have CKD in 2012, and continued to undergo checkups (aged 40-74 years). We examined the risk factors for new-onset CKD and 1...
May 20, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38734869/protocol-for-the-nationwide-registry-of-patients-with-polycystic-kidney-disease-japanese-national-registry-of-pkd-jrp
#55
JOURNAL ARTICLE
Shinya Nakatani, Haruna Kawano, Mai Sato, Junichi Hoshino, Saori Nishio, Kenichiro Miura, Akinari Sekine, Tatsuya Suwabe, Sumi Hidaka, Hiroshi Kataoka, Eiji Ishikawa, Keiji Shimazu, Kiyotaka Uchiyama, Takuya Fujimaru, Tomofumi Moriyama, Mahiro Kurashige, Wataru Shimabukuro, Fumihiko Hattanda, Tomoki Kimura, Yusuke Ushio, Shun Manabe, Hirofumi Watanabe, Michihiro Mitobe, Koichi Seta, Yosuke Shimada, Hirayasu Kai, Kan Katayama, Daisuke Ichikawa, Hiroki Hayashi, Kazushige Hanaoka, Toshio Mochizuki, Koichi Nakanishi, Ken Tsuchiya, Shigeo Horie, Yoshitaka Isaka, Satoru Muto
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) are major genetic polycystic kidney diseases that can progress to end-stage kidney disease (ESKD). Longitudinal data on the clinical characteristics associated with clinical outcomes in polycystic kidney disease (PKD), including the development of ESKD and cardiovascular disease (CVD) are lacking in Japan. To address this unmet need the authors are establishing a novel, web-based, Nationwide Cohort Registry Study-the Japanese Registry of PKD (JRP)...
May 11, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38713253/essential-points-from-evidence-based-clinical-practice-guideline-for-chronic-kidney-disease-2023
#56
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
May 7, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38709377/prediction-model-for-treatment-response-of-primary-membranous-nephropathy-with-nephrotic-syndrome
#57
JOURNAL ARTICLE
Min Li, Xiaoying Lai, Jun Liu, Yahuan Yu, Xianyi Li, Xuemei Liu
OBJECTIVE: To investigate the predictors and establish a nomogram model for the prediction of the response to treatment in primary membranous nephropathy (PMN) with nephrotic syndrome (NS). METHODS: The clinical, laboratory, pathological and follow-up data of patients with biopsy-proven membranous nephropathy at the Affiliated Hospital of Qingdao University were collected. A total of 373 patients were randomly assigned into development group (n = 262) and validation group (n = 111)...
May 6, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38704765/adolescence-onset-atypical-hemolytic-uremic-syndrome-is-it-different-from-infant-onset
#58
JOURNAL ARTICLE
Kubra Celegen, Bora Gulhan, Kibriya Fidan, Selcuk Yuksel, Neslihan Yilmaz, Aysun Caltik Yılmaz, Beltinge Demircioğlu Kılıç, Ibrahim Gokce, Aslı Kavaz Tufan, Mukaddes Kalyoncu, Hulya Nalcacıoglu, Sare Gulfem Ozlu, Eda Didem Kurt Sukur, Nur Canpolat, Aysun K Bayazit, Elif Çomak, Yılmaz Tabel, Sebahat Tulpar, Mehtap Celakil, Kenan Bek, Cengiz Zeybek, Ali Duzova, Birsin Ozcakar, Rezan Topaloglu, Oguz Soylemezoglu, Fatih Ozaltin
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a rare, mostly complement-mediated thrombotic microangiopathy. The majority of patients are infants. In contrast to infantile-onset aHUS, the clinical and genetic characteristics of adolescence-onset aHUS have not been sufficiently addressed to date. METHODS: A total of 28 patients (21 girls, 7 boys) who were diagnosed as aHUS between the ages of ≥10 years and <18 years were included in this study...
May 5, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38702493/impact-of-covid-19-pandemic-on-care-of-maintenance-hemodialysis-patients-a-multicenter-study
#59
JOURNAL ARTICLE
Yasmine Salah Naga, Ahmed El Keraie, Samar Samy Abd ElHafeez, Rowan Saad Zyada
BACKGROUND: The COVID-19 pandemic posed a challenge to hemodialysis (HD) patients. While most outpatient and elective medical services stopped during lockdown, HD patients continued to visit their dialysis centers. We aimed to assess how the initial phase of the pandemic affected patient care by comparing dialysis adequacy and other parameters of patient care before and during the first 10 months of the COVID-19 pandemic. METHODS: In a retrospective multi-center observational study, all adult dialysis patients in five dialysis centers in Alexandria, Egypt were included...
May 3, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38340247/design-and-rationale-for-an-open-label-randomized-controlled-pilot-trial-to-evaluate-the-changes-in-blood-uremic-toxins-in-patients-with-chronic-kidney-disease-by-dietary-therapy-with-sake-lees
#60
JOURNAL ARTICLE
Toshiaki Tokumaru, Tadashi Toyama, Yusuke Nakade, Hisayuki Ogura, Megumi Oshima, Shiori Nakagawa, Motoe Furuichi, Shinji Kitajima, Norihiko Sakai, Miho Shimizu, Yasunori Iwata, Takashi Wada
BACKGROUND: Patients with chronic kidney disease (CKD) reportedly show dysbiosis, which is the imbalance of gut microbiome. Dysbiosis increases the uremic toxin level in the intestine, and uremic toxins transfer into the blood, causing CKD progression. Sake lees, a traditional Japanese fermented food, may help reduce uremic toxins by altering the gut microbiome. Additionally, D-alanine, which is present in sake lees, may have a renoprotective effect. The present pilot study aims to evaluate the effect of adding sake lees to the standard CKD dietary therapy in reducing blood uremic toxins...
May 2024: Clinical and Experimental Nephrology
journal
journal
32795
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.